Published : Sep-2017
No. of Pages : 130
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Introduction 10
2.1 Point-of-Care (POC) Analyzers Overview 10
3 Products under Development 11
3.1 Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 11
3.2 Point-of-Care (POC) Analyzers - Pipeline Products by Territory 12
3.3 Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path 13
3.4 Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date 14
3.5 Point-of-Care (POC) Analyzers - Ongoing Clinical Trials 15
4 Point-of-Care (POC) Analyzers - Pipeline Products under Development by Companies 16
4.1 Point-of-Care (POC) Analyzers Companies - Pipeline Products by Stage of Development 16
4.2 Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 18
5 Point-of-Care (POC) Analyzers Companies and Product Overview 20
5.1 Akers Biosciences Inc Company Overview 20
5.1.1 Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 20
5.2 Akonni Biosystems Inc Company Overview 22
5.2.1 Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 22
5.3 Alere Inc Company Overview 23
5.3.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 23
5.4 Amplino B.V. Company Overview 24
5.4.1 Amplino B.V. Pipeline Products & Ongoing Clinical Trials Overview 24
5.5 Analytical Diagnostic Solutions Inc Company Overview 25
5.5.1 Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 25
5.6 ApoCell Inc Company Overview 26
5.6.1 ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview 26
5.7 Aquila Diagnostic Systems Inc. Company Overview 27
5.7.1 Aquila Diagnostic Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.8 Atonomics A/S Company Overview 28
5.8.1 Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 28
5.9 Attophotonics Biosciences GmbH Company Overview 29
5.9.1 Attophotonics Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview 29
5.10 Beckman Coulter Inc Company Overview 30
5.10.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 30
5.11 Binghamton University Company Overview 31
5.11.1 Binghamton University Pipeline Products & Ongoing Clinical Trials Overview 31
5.12 Bio-Alternative Medical Devices Ltd Company Overview 32
5.12.1 Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 32
5.13 BioMedomics Inc Company Overview 33
5.13.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 33
5.14 bioMerieux S.A. Company Overview 35
5.14.1 bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview 35
5.15 Biopico Systems Inc. Company Overview 36
5.15.1 Biopico Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.16 Boston University Company Overview 37
5.16.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 37
5.17 CardioGenics Inc Company Overview 39
5.17.1 CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview 39
5.18 Cepheid Company Overview 40
5.18.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 40
5.19 ChipCare Corp Company Overview 44
5.19.1 ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 44
5.20 City, University of London Company Overview 45
5.20.1 City, University of London Pipeline Products & Ongoing Clinical Trials Overview 45
5.21 Co-Diagnostics HBDC, Inc. Company Overview 46
5.21.1 Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
5.22 Exosome Diagnostics Inc Company Overview 47
5.22.1 Exosome Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 47
5.23 Florida International University Company Overview 48
5.23.1 Florida International University Pipeline Products & Ongoing Clinical Trials Overview 48
5.24 Indian Institute of Technology Madras Company Overview 49
5.24.1 Indian Institute of Technology Madras Pipeline Products & Ongoing Clinical Trials Overview 49
5.25 Indiana University Company Overview 50
5.25.1 Indiana University Pipeline Products & Ongoing Clinical Trials Overview 50
5.26 Magna Diagnostics GmbH Company Overview 51
5.26.1 Magna Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 51
5.27 Maxygen-mobile DNA tests Company Overview 52
5.27.1 Maxygen-mobile DNA tests Pipeline Products & Ongoing Clinical Trials Overview 52
5.28 mBio Diagnostics Inc Company Overview 53
5.28.1 mBio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 53
5.29 McKesson Corp Company Overview 54
5.29.1 McKesson Corp Pipeline Products & Ongoing Clinical Trials Overview 54
5.30 MML Ltd Company Overview 55
5.30.1 MML Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
5.31 Molbio Diagnostics Pvt. Ltd. Company Overview 56
5.31.1 Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 56
5.32 Molecular Warehouse Ltd Company Overview 57
5.32.1 Molecular Warehouse Ltd Pipeline Products & Ongoing Clinical Trials Overview 57
5.33 Mologic Ltd Company Overview 58
5.33.1 Mologic Ltd Pipeline Products & Ongoing Clinical Trials Overview 58
5.34 Nalia Systems Ltd Company Overview 59
5.34.1 Nalia Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview 59
5.35 Newcastle University Company Overview 60
5.35.1 Newcastle University Pipeline Products & Ongoing Clinical Trials Overview 60
5.36 Ohmx Corp Company Overview 61
5.36.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 61
5.37 OncoGenesis Company Overview 62
5.37.1 OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview 62
5.38 Pacific Nanoscience, Inc. Company Overview 63
5.38.1 Pacific Nanoscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 63
5.39 Parallax Health Sciences, Inc. Company Overview 64
5.39.1 Parallax Health Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
5.40 Phoenix Biosystems Inc Company Overview 65
5.40.1 Phoenix Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 65
5.41 POC Medical Systems Inc. Company Overview 66
5.41.1 POC Medical Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.42 Pocared Diagnostics Ltd. Company Overview 67
5.42.1 Pocared Diagnostics Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67
5.43 PositiveID Corp Company Overview 68
5.43.1 PositiveID Corp Pipeline Products & Ongoing Clinical Trials Overview 68
5.44 Quanterix Corp Company Overview 70
5.44.1 Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview 70
5.45 Radisens Diagnostics Ltd Company Overview 71
5.45.1 Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 71
5.46 SenGenix Inc Company Overview 72
5.46.1 SenGenix Inc Pipeline Products & Ongoing Clinical Trials Overview 72
5.47 Thermal Gradient Inc Company Overview 73
5.47.1 Thermal Gradient Inc Pipeline Products & Ongoing Clinical Trials Overview 73
5.48 Trinity Biotech Plc Company Overview 75
5.48.1 Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview 75
5.49 Two Pore Guys Inc Company Overview 76
5.49.1 Two Pore Guys Inc Pipeline Products & Ongoing Clinical Trials Overview 76
5.50 University of California Berkeley Company Overview 77
5.50.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 77
5.51 ViroCyt Inc Company Overview 80
5.51.1 ViroCyt Inc Pipeline Products & Ongoing Clinical Trials Overview 80
5.52 Wellstat Diagnostics LLC Company Overview 81
5.52.1 Wellstat Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 81
6 Point-of-Care (POC) Analyzers- Recent Developments 82
6.1 Aug 30, 2017: PositiveID's ExcitePCR Subsidiary Announces FireflyDX-Portable: A Lightweight, Bookbag-sized, Realtime Pathogen Detection System, with Commercial Availability Slated for Summer 2018 82
6.2 Aug 30, 2017: bioMerieux - First-Half 2017 Results 83
6.3 Aug 16, 2017: Two Pore Guys Announces Positive Results from Pilot Point-of-Care Liquid Biopsy Study with UCSF 86
6.4 Aug 08, 2017: PositiveID Successfully Detects Ebola Virus on its Firefly Dx Prototype System 87
6.5 Jul 27, 2017: McKesson Reports Fiscal 2018 First-Quarter Results 88
6.6 Jul 20, 2017: bioMerieux - Second-Quarter 2017 Business Review 89
6.7 Jul 18, 2017: Quanterix Boosts Investments in its Accelerator Lab to Support Rapid Growth of Simoa Technology 92
6.8 Jul 18, 2017: Quanterix, Partners Develop PCR-free miRNA Detection Method for Liver Toxicity Testing 93
6.9 Jun 21, 2017: Diabetes Research Unit Cymru confirms EKF POCT HbA1c testing comparable to lab-based HPLC 94
6.10 Jun 15, 2017: Zenosense: Issuance of U.S. MIDS Patent 94
6.11 May 31, 2017: Exosome Diagnostics Will Demonstrate the "Shahky" Point of Care Protein Detection Instrument at American Society for Clinical Oncology 95
6.12 May 24, 2017: PositiveID Forms ExcitePCR Subsidiary to Better Position its Firefly Dx System for $19 Billion Global Point-of-Care Diagnostics Market 96
6.13 May 18, 2017: McKesson Reports Fiscal 2017 Fourth-Quarter and Full-Year Results 96
6.14 Apr 20, 2017: bioMerieux - First-Quarter 2017 Business Review 99
6.15 Mar 02, 2017: McKesson Provides Financial Update to Reflect Creation of a New Healthcare Information Technology Company 102
6.16 Feb 16, 2017: New study reaffirms Quo-Test A1c meets IFCC performance criteria 103
6.17 Feb 03, 2017: Exosome Diagnostics Announces Early Access Program for "Shahky" - Exosome Protein Interrogation Instrument 104
6.18 Jan 26, 2017: Vantage Oncology's 50 Centers and More Than 350 Affiliated Physicians Join The US Oncology Network 105
6.19 Jan 25, 2017: McKesson Reports Fiscal 2017 Third-Quarter Results 106
6.20 Jan 23, 2017: Zenosense: New Patent Application for Additional MIDS Detection Method 108
6.21 Jan 19, 2017: bioMerieux - Fourth-Quarter 2016 Business Review 109
6.22 Jan 17, 2017: McKesson Finalizes Settlement with U.S. Department of Justice and U.S. Drug Enforcement Administration to Resolve Past Claims 112
6.23 Jan 11, 2017: GenePOC Announces CE Marking for its Revogene Instrument 113
6.24 Jan 05, 2017: McKesson and Change Healthcare Announce New Company Will Be Named Change Healthcare 113
6.25 Jan 04, 2017: Exosome Diagnostics Runs World's First Point of Care Liquid Biopsy Instrument Within Leading Boston Hospital 114
6.26 Dec 28, 2016: McKesson Completes Acquisition of Rexall Health and Appoints Domenic Pilla as CEO of McKesson Canada 115
6.27 Dec 21, 2016: McKesson and Change Healthcare Announce Termination off Hart-Scott-Rodino Act Waiting Period for the Creation of a New Healthcare Information Technology Company 116
6.28 Dec 08, 2016: Exosome Diagnostics Announces the First Instrument for Point of Care Liquid Biopsy 116
6.29 Nov 29, 2016: Beckman Coulter announces significant investment in UK microbiology market with DxN VERIS Molecular Diagnostics System 117
6.30 Nov 15, 2016: PositiveID to Exhibit Firefly Dx System at the AMSUS Federal Health 2016 Conference 117
6.31 Nov 07, 2016: Pierre Boulud appointed Corporate Vice Presidentof the Asia Pacific region at bioMerieux 117
6.32 Oct 31, 2016: Zenosense MIDS Cardiac Bench Reader Development 118
6.33 Oct 27, 2016: McKesson Reports Fiscal 2017 Second-Quarter Results and Revised Fiscal 2017 Outlook 118
6.34 Oct 24, 2016: McKesson Releases Fiscal 2016 Corporate Social Responsibility Report 120
6.35 Oct 20, 2016: ViroCyt Develops Rapid Detection System For Enterovirus 71 121
6.36 Oct 20, 2016: bioMerieux-Business Review for the nine months ended September 30, 2016 122
6.37 Oct 04, 2016: Trinity Biotech Announces FDA 510(k) Submission withdrawal for Meritas Point of Care Analyzer 124
6.38 Sep 19, 2016: Zenosense General Update - Cardiac Device Development 125
7 Appendix 127
7.1 Methodology 127
7.2 About GlobalData 130
7.3 Contact Us 130
7.4 Disclaimer 130
1.1 List of Tables
Table 1: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 11
Table 2: Point-of-Care (POC) Analyzers - Pipeline Products by Territory 12
Table 3: Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path 13
Table 4: Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date 14
Table 5: Point-of-Care (POC) Analyzers - Ongoing Clinical Trials 15
Table 6: Point-of-Care (POC) Analyzers Companies - Pipeline Products by Stage of Development 16
Table 7: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 18
Table 8: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 20
Table 9: minDNAnalyzer - Product Status 20
Table 10: minDNAnalyzer - Product Description 21
Table 11: Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 22
Table 12: TruDx 2000 Platform - Product Status 22
Table 13: TruDx 2000 Platform - Product Description 22
Table 14: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 23
Table 15: Clondiag HIV Molecular Device - Product Status 23
Table 16: Clondiag HIV Molecular Device - Product Description 23
Table 17: Amplino B.V. Pipeline Products & Ongoing Clinical Trials Overview 24
Table 18: Scout PCR Analyzer - Product Status 24
Table 19: Scout PCR Analyzer - Product Description 24
Table 20: Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 25
Table 21: POC Device - Malaria - Product Status 25
Table 22: POC Device - Malaria - Product Description 25
Table 23: ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 24: ApoStream System - Product Status 26
Table 25: ApoStream System - Product Description 26
Table 26: Aquila Diagnostic Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
Table 27: Accutas Malaria Diagnostic System - Product Status 27
Table 28: Accutas Malaria Diagnostic System - Product Description 27
Table 29: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 28
Table 30: Atolyzer PoC - Product Status 28
Table 31: Atolyzer PoC - Product Description 28
Table 32: Attophotonics Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview 29
Table 33: Nanoparticle Microfluidic Color Device - Product Status 29
Table 34: Nanoparticle Microfluidic Color Device - Product Description 29
Table 35: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 30
Table 36: DxN VERIS MDx System - Product Status 30
Table 37: DxN VERIS MDx System - Product Description 30
Table 38: Binghamton University Pipeline Products & Ongoing Clinical Trials Overview 31
Table 39: U-PAC - Product Status 31
Table 40: U-PAC - Product Description 31
Table 41: Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 32
Table 42: Magnetic Immunoassay Detection System - Product Status 32
Table 43: Magnetic Immunoassay Detection System - Product Description 32
Table 44: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 45: Next Generation Ultra-sensitive Nanotube Platform - Product Status 33
Table 46: Next Generation Ultra-sensitive Nanotube Platform - Product Description 33
Table 47: TR-LFIA Diagnostic Platform - Product Status 34
Table 48: TR-LFIA Diagnostic Platform - Product Description 34
Table 49: bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview 35
Table 50: Magnotech System - Product Status 35
Table 51: Magnotech System - Product Description 35
Table 52: Biopico Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
Table 53: MONITOR System - Product Status 36
Table 54: MONITOR System - Product Description 36
Table 55: Boston University Pipeline Products & Ongoing Clinical Trials Overview 37
Table 56: Molecular Diagnostic Device - Sexually Transmitted Infections - Product Status 37
Table 57: Molecular Diagnostic Device - Sexually Transmitted Infections - Product Description 37
Table 58: Point-Of-Care Device - Allergen-Specific IgE - Product Status 38
Table 59: Point-Of-Care Device - Allergen-Specific IgE - Product Description 38
Table 60: CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview 39
Table 61: QL Care Analyzer - Product Status 39
Table 62: QL Care Analyzer - Product Description 39
Table 63: Cepheid Pipeline Products & Ongoing Clinical Trials Overview 40
Table 64: GeneXpert Omni - Product Status 40
Table 65: GeneXpert Omni - Product Description 40
Table 66: GeneXpert Omni CLIA-Waived Point-of-Care System - Product Status 41
Table 67: GeneXpert Omni CLIA-Waived Point-of-Care System - Product Description 41
Table 68: Cepheid - Ongoing Clinical Trials Overview 42
Table 69: GeneXpert Omni - Xpert Omni Performance Evaluation for Linkage to Tuberculosis Care: The XPEL TB Trial 43
Table 70: ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 44
Table 71: Polyvalent Analyzer (PAx) - Product Status 44
Table 72: Polyvalent Analyzer (PAx) - Product Description 44
Table 73: City, University of London Pipeline Products & Ongoing Clinical Trials Overview 45
Table 74: POC Device - Mood Disorders - Product Status 45
Table 75: POC Device - Mood Disorders - Product Description 45
Table 76: Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
Table 77: LightPCR - Product Status 46
Table 78: LightPCR - Product Description 46
Table 79: Exosome Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 47
Table 80: Shahky - Product Status 47
Table 81: Shahky - Product Description 47
Table 82: Florida International University Pipeline Products & Ongoing Clinical Trials Overview 48
Table 83: Cortisol Detector - Product Status 48
Table 84: Cortisol Detector - Product Description 48
Table 85: Indian Institute of Technology Madras Pipeline Products & Ongoing Clinical Trials Overview 49
Table 86: Microfluidic Flow Analyzer - Product Status 49
Table 87: Microfluidic Flow Analyzer - Product Description 49
Table 88: Indiana University Pipeline Products & Ongoing Clinical Trials Overview 50
Table 89: Microfluidic Device - Cancer - Product Status 50
Table 90: Microfluidic Device - Cancer - Product Description 50
Table 91: Magna Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 51
Table 92: MAZER System - Product Status 51
Table 93: MAZER System - Product Description 51
Table 94: Maxygen-mobile DNA tests Pipeline Products & Ongoing Clinical Trials Overview 52
Table 95: Maxygen POC Device - Product Status 52
Table 96: Maxygen POC Device - Product Description 52
Table 97: mBio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 53
Table 98: MBio CD4 System - Product Status 53
Table 99: MBio CD4 System - Product Description 53
Table 100: McKesson Corp Pipeline Products & Ongoing Clinical Trials Overview 54
Table 101: Proventys PDx System - Product Status 54
Table 102: Proventys PDx System - Product Description 54
Table 103: MML Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
Table 104: MIDS Cardiac - Product Status 55
Table 105: MIDS Cardiac - Product Description 55
Table 106: Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 56
Table 107: Truelab Quattro Analyzer - Product Status 56
Table 108: Truelab Quattro Analyzer - Product Description 56
Table 109: Molecular Warehouse Ltd Pipeline Products & Ongoing Clinical Trials Overview 57
Table 110: Portable Biosensor Device - Product Status 57
Table 111: Portable Biosensor Device - Product Description 57
Table 112: Mologic Ltd Pipeline Products & Ongoing Clinical Trials Overview 58
Table 113: ACuTEGA - Product Status 58
Table 114: ACuTEGA - Product Description 58
Table 115: Nalia Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview 59
Table 116: NALIA Single-Patient Point-Of-Care Device - Product Status 59
Table 117: NALIA Single-Patient Point-Of-Care Device - Product Description 59
Table 118: Newcastle University Pipeline Products & Ongoing Clinical Trials Overview 60
Table 119: SmartHEALTH POC System - Colorectal Cancer - Product Status 60
Table 120: SmartHEALTH POC System - Colorectal Cancer - Product Description 60
Table 121: Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 61
Table 122: Handheld Clinical Analyzer - Product Status 61
Table 123: Handheld Clinical Analyzer - Product Description 61
Table 124: OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview 62
Table 125: Genesis Point-Of-Care Diagnostic System - Product Status 62
Table 126: Genesis Point-Of-Care Diagnostic System - Product Description 62
Table 127: Pacific Nanoscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 63
Table 128: Nanomonitor - Product Status 63
Table 129: Nanomonitor - Product Description 63
Table 130: Parallax Health Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
Table 131: SPARKS Mobile - Product Status 64
Table 132: SPARKS Mobile - Product Description 64
Table 133: Phoenix Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 65
Table 134: Point of Care HIV Combo Device - Product Status 65
Table 135: Point of Care HIV Combo Device - Product Description 65
Table 136: POC Medical Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
Table 137: Pandora CDx Point-of-Care System - Product Status 66
Table 138: Pandora CDx Point-of-Care System - Product Description 66
Table 139: Pocared Diagnostics Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67
Table 140: POCARED P-1000 - Product Status 67
Table 141: POCARED P-1000 - Product Description 67
Table 142: PositiveID Corp Pipeline Products & Ongoing Clinical Trials Overview 68
Table 143: Firefly Dx System - Product Status 68
Table 144: Firefly Dx System - Product Description 69
Table 145: Firefly Dx System - Zika Virus - Product Status 69
Table 146: Firefly Dx System - Zika Virus - Product Description 69
Table 147: Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview 70
Table 148: Simoa 5.0 - Product Status 70
Table 149: Simoa 5.0 - Product Description 70
Table 150: Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 71
Table 151: Radisens Instrument - Product Status 71
Table 152: Radisens Instrument - Product Description 71
Table 153: SenGenix Inc Pipeline Products & Ongoing Clinical Trials Overview 72
Table 154: SenGenix Strips And Reader System - Product Status 72
Table 155: SenGenix Strips And Reader System - Product Description 72
Table 156: Thermal Gradient Inc Pipeline Products & Ongoing Clinical Trials Overview 73
Table 157: FlashDirect-HC - Product Status 73
Table 158: FlashDirect-HC - Product Description 73
Table 159: FlashDirect-LC - Product Status 74
Table 160: FlashDirect-LC - Product Description 74
Table 161: Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview 75
Table 162: Meritas Point of Care Analyzer - Product Status 75
Table 163: Meritas Point of Care Analyzer - Product Description 75
Table 164: Two Pore Guys Inc Pipeline Products & Ongoing Clinical Trials Overview 76
Table 165: Handheld Nanopore Based Device - Cancer - Product Status 76
Table 166: Handheld Nanopore Based Device - Cancer - Product Description 76
Table 167: University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 77
Table 168: Microfluidic Blotting Device - Product Status 77
Table 169: Microfluidic Blotting Device - Product Description 77
Table 170: Mobile Molecular Diagnostics System - Product Status 78
Table 171: Mobile Molecular Diagnostics System - Product Description 78
Table 172: Multi-dimensional Microfluidic Device - Product Status 78
Table 173: Multi-dimensional Microfluidic Device - Product Description 78
Table 174: Point-Of-Care Microfluidic Device - Acute Promyelocytic Leukemia - Product Status 79
Table 175: Point-Of-Care Microfluidic Device - Acute Promyelocytic Leukemia - Product Description 79
Table 176: ViroCyt Inc Pipeline Products & Ongoing Clinical Trials Overview 80
Table 177: ViroTag EV71 - Product Status 80
Table 178: ViroTag EV71 - Product Description 80
Table 179: Wellstat Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 81
Table 180: Electrochemiluminescent Based RNA Detection Platform - Product Status 81
Table 181: Electrochemiluminescent Based RNA Detection Platform - Product Description 81
Table 182: Glossary 129
1.2 List of Figures
Figure 1: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 11
Figure 2: Point-of-Care (POC) Analyzers - Pipeline Products by Territory 12
Figure 3: Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path 13
Figure 4: Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date 14
Figure 5: Point-of-Care (POC) Analyzers - Ongoing Clinical Trials 15
